Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Tumor Ablation Market, By Technology
7.1. Tumor Ablation Market, By Technology Type, 2020-2030
7.1.1. Radiofrequency ablation
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Microwave ablation
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Cryoablation
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. Irreversible electroporation ablation
7.1.4.1. Market Revenue and Forecast (2016-2030)
7.1.5. Other ablation technologies
7.1.5.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Tumor Ablation Market, By Treatment
8.1. Tumor Ablation Market, By Treatment, 2020-2030
8.1.1. Surgical ablation
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Laparoscopic ablation
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Percutaneous ablation
8.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Tumor Ablation Market, Application
9.1. Tumor Ablation Market, Application, 2020-2030
9.1.1. Kidney Cancer
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Liver cancer
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Breast cancer
9.1.3.1. Market Revenue and Forecast (2016-2030)
9.1.4. Lung cancer
9.1.4.1. Market Revenue and Forecast (2016-2030)
9.1.5. Prostate cancer
9.1.5.1. Market Revenue and Forecast (2016-2030)
9.1.6. Other cancer
9.1.6.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Tumor Ablation Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, By Technology (2016-2030)
10.1.2. Market Revenue and Forecast, By Treatment (2016-2030)
10.1.3. Market Revenue and Forecast, Application (2016-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, By Technology (2016-2030)
10.1.4.2. Market Revenue and Forecast, By Treatment (2016-2030)
10.1.4.3. Market Revenue and Forecast, Application (2016-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, By Technology (2016-2030)
10.1.5.2. Market Revenue and Forecast, By Treatment (2016-2030)
10.1.5.3. Market Revenue and Forecast, Application (2016-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, By Technology (2016-2030)
10.2.2. Market Revenue and Forecast, By Treatment (2016-2030)
10.2.3. Market Revenue and Forecast, Application (2016-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, By Technology (2016-2030)
10.2.4.2. Market Revenue and Forecast, By Treatment (2016-2030)
10.2.4.3. Market Revenue and Forecast, Application (2016-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, By Technology (2016-2030)
10.2.5.2. Market Revenue and Forecast, By Treatment (2016-2030)
10.2.5.3. Market Revenue and Forecast, Application (2016-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, By Technology (2016-2030)
10.2.6.2. Market Revenue and Forecast, By Treatment (2016-2030)
10.2.6.3. Market Revenue and Forecast, Application (2016-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, By Technology (2016-2030)
10.2.7.2. Market Revenue and Forecast, By Treatment (2016-2030)
10.2.7.3. Market Revenue and Forecast, Application (2016-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, By Technology (2016-2030)
10.3.2. Market Revenue and Forecast, By Treatment (2016-2030)
10.3.3. Market Revenue and Forecast, Application (2016-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, By Technology (2016-2030)
10.3.4.2. Market Revenue and Forecast, By Treatment (2016-2030)
10.3.4.3. Market Revenue and Forecast, Application (2016-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, By Technology (2016-2030)
10.3.5.2. Market Revenue and Forecast, By Treatment (2016-2030)
10.3.5.3. Market Revenue and Forecast, Application (2016-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, By Technology (2016-2030)
10.3.6.2. Market Revenue and Forecast, By Treatment (2016-2030)
10.3.6.3. Market Revenue and Forecast, Application (2016-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, By Technology (2016-2030)
10.3.7.2. Market Revenue and Forecast, By Treatment (2016-2030)
10.3.7.3. Market Revenue and Forecast, Application (2016-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, By Technology (2016-2030)
10.4.2. Market Revenue and Forecast, By Treatment (2016-2030)
10.4.3. Market Revenue and Forecast, Application (2016-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, By Technology (2016-2030)
10.4.4.2. Market Revenue and Forecast, By Treatment (2016-2030)
10.4.4.3. Market Revenue and Forecast, Application (2016-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, By Technology (2016-2030)
10.4.5.2. Market Revenue and Forecast, By Treatment (2016-2030)
10.4.5.3. Market Revenue and Forecast, Application (2016-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, By Technology (2016-2030)
10.4.6.2. Market Revenue and Forecast, By Treatment (2016-2030)
10.4.6.3. Market Revenue and Forecast, Application (2016-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, By Technology (2016-2030)
10.4.7.2. Market Revenue and Forecast, By Treatment (2016-2030)
10.4.7.3. Market Revenue and Forecast, Application (2016-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, By Technology (2016-2030)
10.5.2. Market Revenue and Forecast, By Treatment (2016-2030)
10.5.3. Market Revenue and Forecast, Application (2016-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, By Technology (2016-2030)
10.5.4.2. Market Revenue and Forecast, By Treatment (2016-2030)
10.5.4.3. Market Revenue and Forecast, Application (2016-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, By Technology (2016-2030)
10.5.5.2. Market Revenue and Forecast, By Treatment (2016-2030)
10.5.5.3. Market Revenue and Forecast, Application (2016-2030)
Chapter 11. Company Profiles
11.1. Galil Medical Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Misonix Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. HealthTronics
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Mermaid Medical
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Theraclion
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Chongqing Haifu Medical Technology Co., Ltd.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. HS Hospital Service S.P.A
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. EDAP TMS S.A.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
Glossary of Terms